Pazopanib maintenance after first-line etoposide and platinum chemotherapy in patients with extensive disease small-cell lung cancer: a multicentre, randomised, placebo-controlled Phase II study (KCSG-LU12-07)

BACKGROUND: We investigated whether pazopanib maintenance following first-line chemotherapy would improve survival in patients with extensive disease small-cell lung cancer (ED-SCLC). METHODS: This study is a randomised, placebo-controlled, phase II study that enroled ED-SCLC patients who had not pr...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Br J Cancer
Päätekijät: Sun, Jong-Mu, Lee, Ki Hyeong, Kim, Bong-Seog, Kim, Hoon-Gu, Min, Young Joo, Yi, Seong Yoon, Yun, Hwan Jung, Jung, Sin-Ho, Lee, Se-Hoon, Ahn, Jin Seok, Park, Keunchil, Ahn, Myung-Ju
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Nature Publishing Group 2018
Aiheet:
Clinical Study
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5846070/
https://ncbi.nlm.nih.gov/pubmed/29381690
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2017.465
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia